BIOTRANSFORMATION AND EXCRETION OF LORAZEPAM IN PATIENTS WITH CHRONIC RENAL FAILURE-Reference-Cited by-同舟云学术

BIOTRANSFORMATION AND EXCRETION OF LORAZEPAM IN PATIENTS WITH CHRONIC RENAL FAILURE

Published:1976-12 Issue:6 Volume:3 Page:1033-1039
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:

Author:

VERBEECK R.,TJANDRAMAGA T.B.,VERBERCKMOES R.,SCHEPPER P.J.

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2125.1976.tb00354.x/fullpdf

Reference10 articles.

1. The determination of 7-chloro-1,3-dihydro-5-(2′, chlorophenyl)-2H-1,4-benzodiazepin-2-one (Ro 5-3027) and its metabolite (lorazepam) in blood and urine by electron-capture gas liquid chromatography;Silva;J. chromatog. Sci.,1973

2. Pharmacology of 7-chloro-5-(0-chlorophenyl)-1,3-dihydro-3-hydroxy-2H-1,4-benzodiazepin-2-one (lorazepam, WY 4036);Gluckman;Arzneimittel-Forsch. (Drug Res.),1971

3. Evaluation of a new tranquilizer -WY. 4036-in the treatment of anxiety;Haider;Br. J. Psychiat.,1971

4. Disposition of 7-chloro-5-(0-chlorophenyl)-1,3 - dihydro - 3-hydroxy-2H1,4 -benzodiazepin-2-one (lorazepam) in humans;Knowles;Arzneimittel-Forsch. (Drug Res.),1971

5. WY 4036 (lorazepam): A study of its use in premedication;Norris;Br. J. Anaesth.,1971

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evidence-based consensus guidelines for the management of catatonia: Recommendations from the British Association for Psychopharmacology;Journal of Psychopharmacology;2023-04

2. Spezifische Aspekte der Arzneimitteltherapie in der Palliativmedizin;Arzneimitteltherapie in der Palliativmedizin;2022

3. Anxiety Presentations and Treatments in Populations With Kidney Disease;Seminars in Nephrology;2021-11

4. Ontogeny of Drug-Metabolizing Enzymes;Methods in Molecular Biology;2021

5. Special Populations;Demystifying Drug Dosing in Renal Dysfunction;2019-05-31